Ergebnis der Suchanfrage nach Rh&ouml

TÜV Rheinland AG

2

Solar Energy Conference by TÜV Rheinland: new technologies, new regulation, new test methods, new failure patterns

Medigene AG

euro adhoc: MediGene AG / MediGene's First Drug Eligard® Is Launched (E)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried - San Diego, May 4, 2004. Eligard®, the first drug of the German-American biotechnology company MediGene AG (Frankfurt, Prime Standard: MDG), is available in German pharmacies today. With the launch of the prescription drug to treat ...

Medigene AG

euro adhoc: MediGene AG / MediGene Receives Approval for Anti-cancer Drug LeuprogelÒ (Eligard®) First drug approval for a German biotechnology company (E)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried - San Diego, December 2, 2003: As the first German biotechnology company, MediGene AG (Frankfurt, Prime Standard: MDG) has received marketing authorization for a drug. The ...